Previous clinical studies have shown that bacterial, fungal, or viral infections can lead to early activation of complement component 3 (C3), resulting in depletion of plasma C3 and upregulation of C3 cleavage forms, including C3a and C3b (Conigliaro et al., 2019). Here, C3 is linked to viral infectious disease.